Building a Pharmacological Lexicon: Small Molecule Discovery in Academia
- 3 April 2007
- journal article
- review article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Molecular Pharmacology
- Vol. 72 (1), 1-7
- https://doi.org/10.1124/mol.107.035113
Abstract
Small molecules are powerful pharmacological tools to dissect biological events. There is now considerable interest in expanding efforts to identify and use small molecules targeting proteins encoded in the genomes of humans and pathogenic organisms. Integration of the principles of molecular pharmacology with contemporary high-throughput and high-content screening technologies is essential for the success of these discovery activities. We present some of the challenges and opportunities provided by the Molecular Library Screening Centers Network (MLSCN), which is a National Institutes of Health Roadmap Initiative.Keywords
This publication has 12 references indexed in Scilit:
- Small-Molecule Screening: It Takes a VillageACS Chemical Biology, 2007
- Roadmap or Roadkill: A Pharmacologist's Analysis of the NIH Molecular Libraries InitiativeMolecular Interventions, 2006
- Can open-source R&D reinvigorate drug research?Nature Reviews Drug Discovery, 2006
- Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical librariesProceedings of the National Academy of Sciences of the United States of America, 2006
- Planning science (a generation after Lewis Thomas)JCI Insight, 2006
- Rescuing the NIH before it is too lateJCI Insight, 2006
- An inhibitor of Bcl-2 family proteins induces regression of solid tumoursNature, 2005
- Tough Times Ahead for the Genome ProjectScience, 1990
- Hard Times at NIHScience, 1989
- Plan for Genome Centers Sparks a ControversyScience, 1989